|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Laparoscopic sleeve gastrectomy:More than a restrictive bariatric surgery procedure?显示文摘Sleeve gastrectomy(SG) is a restrictive bariatric surgery technique that was first used as part of restrictive horizontal gastrectomy in the original Scopinaro type biliopancreatic diversion. Its good results as a single technique have led to a rise in its use, and it is currently the second most performed technique worldwide. SG achieves clearly better results than other restrictive techniques and is comparable in some aspects to the Roux-en-Y gastric bypass, the current gold standard in bariatric surgery. These benefits have been associated with different pathophysiologic mechanisms unrelated to weight loss such as increased gastric emptying and intestinal transit, and activation of hormonal mechanisms such as increased GLP-1 hormone and decreased ghrelin. The aim of this review was to highlight the salient aspects of SG regarding its historical evolution, pathophysiologic mechanisms, main results, clinical applications and perioperative complications. | David Benaiges Antonio Más-Lorenzo Albert Goday José M Ramon Juan J Chillarón Juan Pedro-Botet Juana A Flores-Le Roux | 2015 | World Journal of Gastroenterology2015，21，41： | 6 |
| 2 | 外科减肥手术后高血压缓解和复发的预测因素显示文摘目前,只有很少量研究涉及外科减肥手术后高血压得到缓解和复发的影响因素,没有可用于预测高血压复发相关因素的信息。该研究的目的是评估在外科减肥手术后第1年和第3年里高血压的缓解情况和复发率,并寻找可能的预测因素。 | Benaiges D Sagué M Flores-Le Roux JA Pedro-Botet J Ramón JM Villatoro M Chillarón JJ Pera M Más A Grande L Goday A 陈云 | 2016 | 中华高血压杂志2016，24，9： | 2 |
| 3 | Mammary hamartoma显示文摘 | Ruiz Tovar J Reguero Callejas ME A1áez Chillarón AB | | 0，，： | 1 |
| 4 | The light subunit of system bo, + is fully functional in the absence of the heavy subunit 显示文摘 | REIG N CHILLAR N J BARTOCCIONI P | 2002 | The EMBO Journal2002，21，： | 1 |
| 5 | Reboxetine: a novel antidepressant 显示文摘 | Kadhe N G Chillar A J Deshmukh Y A | 2003 | J Postgrad Med2003，49，： | 1 |
| 6 | Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen显示文摘The prevalence of type 2 diabetes mellitus(T2DM) has risen in recent decades, and cardiovascular disease remains the leading cause of death in this population. Several clinical trials have demonstrated the benefit of tight control of risk factors on the incidence and mortality of cardiovascular disease. However, in clinical practice, few patients achieve the therapeutic goals. The current diagnostic procedures for subclinical cardiovascular disease in T2 DM patients have not been shown to improve prognosis or mortality, probably because they do not categorize cardiovascular risk. Thus, clinical practice guidelines do not systematically recommend screening for subclinical atherosclerosis in these patients, although it is known that patients with extracoronary atherosclerosis, microangiopathy and poorlycontrolled cardiovascular risk factors are at high risk for cardiovascular disease. Improvements in the reliability of diagnostic tests, with fewer side effects and better cost efficiency, may better help to stratify cardiovascular risk in this group of patients, and further evaluation on this topic should be considered. | Juan J Chillarón Juana A Flores-Le Roux David Benaiges Juan Pedro-Botet | 2014 | World Journal of Clinical Cases2014，2，9： | 1 |
| 7 | High power optically pumped semiconductor lasers 显示文摘 | Chillar J Butterworth S Zeitschel A | 2004 | SPIE2004，5332，： | 1 |
| 8 | Blue and green optically-pumped semiconductor lasers for display 显示文摘 | Chillar J L A Zhou H Weiss E | 2005 | SPIE2005，5740，： | 1 |
| 9 | Statins for primary cardiovascular prevention in the elderly显示文摘老人口全球正在增加,与题目 >组成快成长的年龄组的 65 岁。而且,老脸心血管的疾病死亡和病态的最大的风险和负担。尽管老病人,特别地那些更旧的 >75,很好没在评估类脂化合物阴沉的治疗的使随机化的临床的审判被代表,在更老的个人在主要预防支持 statin 治疗的使用的可得到的证据主要从亚群分析和 hoc 以后的数据被导出。在另一方面,老病人经常有要求并发的药的一个高数字的多重合作病态;这可以为药药相互作用增加风险,从而减少 statin 的潜在的好处治疗。这评论的目的是关于 statin 使用介绍相关文学在为他们的主要心血管的疾病老,与治疗的联系风险和好处。 | Juan Pedro-Botet Elisenda Climent Juan J Chillarón Rocio Toro David Benaiges Juana A Flores-Le Roux | 2015 | Journal of Geriatric Cardiology2015，12，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员